Portal de investigación
ESTUDIO ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO, MULTICENTRICO, FASE 3 DE DENOSUMAB EN LA PROLONGACION DE LA SUPERVIVENCIA LIBRE DE METASTASIS OSEAS EN HOMBRES CON CANCER DE PROSTATA HORMONORREFRACTARIO.
Datos básicos
- Protocolo:
- 20050147
- EUDRACT:
- 2005-005485-37
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Año de incio:
- Año de finalización:
Documentos
- No hay documentos
Participantes
Resultados del Ensayo Clínico
Asymptotic modeling of electrochemical signaling: Testing Zn in urine for non-invasive bladder cancer diagnosis
Domenech-Carbo, A; (...); Ramos, D
Article. 10.1016/j.snb.2021.130646. 2021
Biological significance of cribriform pattern in radical prostatectomy specimens: Study of its prognostic significance in biochemical recurrence
Gomez, PF; (...); Boronat, TF
Meeting Abstract. 2021
Bladder cancer patients have increased NETosis and impaired DNaseI-mediated NET degradation that can be therapeutically restored in vitro.
Article. 10.3389/fimmu.2023.1171065. 2023
Circulating Cell-Free DNA in Liquid Biopsies as Potential Biomarker for Bladder Cancer: A Systematic Review
Herranz, R; (...); Medina, P
Review. 10.3390/cancers13061448. 2021
Effect of different schemes of androgen deprivation therapy on bone mass density in prostate cancer patients.
Arevalo Ruales, Karla; (...); Roman Ivorra, Jose Andres
Article. 10.1016/j.medcli.2022.03.026. 2023
Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization.
Giner Moreno E; (...); Ramos Soler D
Article. 10.3791/65635. 2023
Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer
Loras, A, Segovia, C, Ruiz-Cerda, JL
Review. 10.3390/cancers13112719. 2021
Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs
Article. 10.3390/ijms22157913. 2021
Identification of miR-29c-3p as a Robust Normalizer for Urine microRNA Studies in Bladder Cancer.
Article. 10.3390/biomedicines8110447. 2020
Impact of aging on the incidence and mortality of urological cancers: 20-year projection in Spain
Gomez-Palomo, F.; (...); Ruiz Cerda, J. L.
Article. 10.1016/j.acuro.2021.10.001. 2022
Impact of aging on the incidence and mortality of urological cancers: 20-year projection in Spain.
Gomez-Palomo, F; (...); Ruiz Cerda, J L
Article. 10.1016/j.acuroe.2021.10.004. 2022
Long-Term Experience with Hyperthermic Chemotherapy (HIVEC) Using Mitomycin-C in Patients with Non-Muscle Invasive Bladder Cancer in Spain.
Plata A; (...); Angulo JC
Article. 10.3390/jcm10215105. 2021
Nuclear-medicine probes: Where we are and where we are going
Gonzalez-Montoro A; (...); Javier Gonzalez, Antonio
Article. 10.1002/mp.15690. 2022
Prostate cancer chemotherapy by intratumoral administration of Docetaxel-Mesoporous silica nanomedicines.
Rivero-Buceta, Eva; (...); Botella, Pablo
Article. 10.1016/j.ijpharm.2024.124623. 2024
Sildenafil Citrate Enhances Renal Organogenesis Following Metanephroi Allotransplantation into Non-Immunosuppressed Hosts.
Garcia-Dominguez, Ximo; (...); Marco-Jimenez, Francisco
Article. 10.3390/jcm11113068. 2022
The sentinel node with technetium-99m for prostate cancer. A safe and, mature new gold standard?
Perez-Ardavin J; (...); Vera-Donoso CD
Article. 10.23736/S1824-4785.22.03416-1. 2022
Validation of urine p-cresol glucuronide as renal cell carcinoma non-invasive biomarker
Oto, Julia; (...); Medina, Pilar
Article. 10.1016/j.jprot.2024.105357. 2025